Page 109 - 《中国药房》2024年22期

safety of rivaroxaban for the prevention of thrombosis fol‐ bolism following primary total hip arthroplasty in low-risk
lowing total hip or knee replacement：a systematic review patients when using aspirin for prophylaxis[J]. Hip Int，
and meta-analysis[J]. Medicine，2019，98（9）：e14539. 2022，32（5）：562-567.
[34] GAO J H，CHU X C，WANG L L，et al. Effects of diffe- [43] FUJI T，NAKAMURA M，TAKEUCHI M. Darexaban for
rent anticoagulant drugs on the prevention of complica‐ the prevention of venous thromboembolism in Asian pa‐
tions in patients after arthroplasty：a network meta-analysis tients undergoing orthopedic surgery：results from 2 ran‐
[J]. Medicine，2017，96（40）：e8059. domized，placebo-controlled，double-blind studies[J]. Clin
[35] XU J，CHANG D，CHUI J，et al. The efficacy and cost- Appl Thromb Hemost，2014，20（2）：199-211.
effectiveness of enoxaparin versus rivaroxaban in the pre‐ [44] LASSEN M R，BORRIS L C，JENSEN H P，et al. Dose re‐
vention of venous thromboembolism following total hip lation in the prevention of proximal vein thrombosis with
or knee arthroplasty：a meta-analysis[J]. J Orthop，2022， a low molecular weight heparin （tinzaparin） in elective
30：1-6. hip arthroplasty[J]. Clin Appl Thromb Hemost，2000，6
[36] HUANG Z H，XU X R，XU D，et al. Efficacy of 11 antico‐ （1）：53-57.
agulants for the prevention of venous thromboembolism [45] FUJI T，FUJITA S，TACHIBANA S，et al. A dose-ranging
after total hip or knee arthroplasty：a systematic review study evaluating the oral factor Ⅹa inhibitor edoxaban for
and network meta-analysis[J]. Medicine，2023，102（2）： the prevention of venous thromboembolism in patients un‐
e32635. dergoing total knee arthroplasty[J]. J Thromb Haemost，
[37] PATHAK R，GIRI S，KARMACHARYA P，et al. Meta- 2010，8（11）：2458-2468.
analysis on efficacy and safety of new oral anticoagulants [46] TURPIE A G，BAUER K A，DAVIDSON B L，et al. A ran‐
for venous thromboembolism prophylaxis in elderly elec‐ domized evaluation of betrixaban，an oral factor Ⅹa inhibi‐
tive postarthroplasty patients[J]. Blood Coagul Fibrinoly‐ tor，for prevention of thromboembolic events after total
sis，2015，26（8）：934-939. knee replacement （EXPERT）[J]. Thromb Haemost，2009，
[38] YI Y H，GONG S，GONG T L，et al. New oral anticoagu‐ 101（1）：68-76.
lants for venous thromboembolism prophylaxis in total [47] 江肃非. 阿哌沙班与依诺肝素预防老年糖尿病患者髋关
hip and knee arthroplasty：a systematic review and net‐ 节置换术后深静脉血栓形成的对比研究[J]. 血栓与止血
work meta-analysis[J]. Front Pharmacol，2021，12： 学，2013，19（4）：150-152.
775126. JIANG S F. The comparative study of apixaban and enoxa‐
[39] FENG W L，WANG X P，HUANG D Q，et al. Ranking parin to prevent elderly diabetic patients with hip arthro‐
the efficacy of anticoagulants for the prevention of venous plasty postoperative deep venous thrombosis[J]. Chin J
thromboembolism after total hip or knee arthroplasty：a Thromb Hemostasis，2013，19（4）：150-152.
systematic review and a network meta-analysis[J]. Phar‐ [48] 卢克鹏，刘彩虹，毕莹 . 预防性抗凝持续时间对全髋/膝
macol Res，2021，166：105438. 关节置换术后静脉血栓形成的影响[J]. 中国临床药理学
[40] HU B S，JIANG L X，TANG H X，et al. Rivaroxaban ver‐ 与治疗学，2023，28（11）：1269-1274.
sus aspirin in prevention of venous thromboembolism fol‐ LU K P，LIU C H，BI Y. Effect of prophylactic anticoagu‐
lowing total joint arthroplasty or hip fracture surgery：a lation duration on venous thrombosis after total hip/knee
meta-analysis[J]. J Orthop Surg Res，2021，16（1）：135. arthroplasty[J]. Chin J Clin Pharmacol Ther，2023，28
[41] MENG J H，LIU W J，XIAO Y F，et al. The role of aspirin （11）：1269-1274.
versus low-molecular-weight heparin for venous thrombo‐ [49] MCDONALD S，PAGE M J，BERINGER K，et al. Pre-
embolism prophylaxis after total knee arthroplasty：a meta- operative education for hip or knee replacement[J]. Co‐
analysis of randomized controlled trials[J]. Int J Surg， chrane Database Syst Rev，2014，2014（5）：CD003526.
2023，109（11）：3648-3655. （收稿日期：2024-05-10 修回日期：2024-09-12）
[42] HOWARD T A，JUDD C S，SNOWDEN G T，et al. Inci‐ （编辑：刘明伟）
dence and risk factors associated with venous thromboem‐

中国药房 2024年第35卷第22期 China Pharmacy 2024 Vol. 35 No. 22 · 2807 ·